DDR1 and chronic myelogenous leukemia, BCR-ABL1 positive: Minor activation of the DDR proteins was detected in the PBMCs of healthy donors, CP-CML patients in DMR or MMR, and CP-CML patients with loss of MMR, which was in accordance with the detection of low levels of DNA damage in these cells, as evidenced by γH2AX foci analysis.